Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$50,924,135
+$4,199,889 QoQ
Shares Held
202,369
-5.8% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#355
of 4,153 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026YOUSIF CAPITAL MANAGEMENT, LLC holds $293,560,933 across 14 Drug Manufacturers - General names. ABBV ranks #3 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
67,889 | $81,428,110 | |
| 2 | JNJ |
Johnson & Johnson
|
269,311 | $68,396,914 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
202,369 | $50,924,135 | |
| 4 | MRK |
Merck & Co., Inc.
|
226,047 | $29,047,039 | |
| 5 | AMGN |
Amgen Inc
|
51,233 | $18,552,493 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
120,084 | $15,171,412 | |
| 7 | PFE |
Pfizer Inc
|
525,468 | $12,653,269 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
194,129 | $11,185,712 |
All Filings in ABBV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,924,135 | 202,369 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $46,724,246 | 214,834 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $50,835,826 | 222,486 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $53,551,960 | 231,286 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $44,138,208 | 237,788 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $50,954,844 | 243,198 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $43,887,102 | 246,973 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $50,858,011 | 257,535 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $44,932,408 | 261,966 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $48,662,765 | 267,231 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $42,090,781 | 271,606 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $42,256,870 | 283,489 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $38,871,760 | 288,516 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $45,652,652 | 286,457 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $48,460,051 | 299,858 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $39,738,373 | 296,091 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $45,743,071 | 298,662 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $49,934,094 | 308,026 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $41,206,011 | 304,328 | Shares | Sole | 2022-01-31 | |
| No filing history on record for this holder in this stock. | ||||||